GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » Cyclically Adjusted Revenue per Share

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Cyclically Adjusted Revenue per Share : ¥3.73 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Tianjin Ringpu Bio-Technology Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥1.157. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.73 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Tianjin Ringpu Bio-Technology Co's average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Tianjin Ringpu Bio-Technology Co was 14.20% per year. The lowest was 9.90% per year. And the median was 12.80% per year.

As of today (2024-05-22), Tianjin Ringpu Bio-Technology Co's current stock price is ¥16.77. Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.73. Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio of today is 4.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tianjin Ringpu Bio-Technology Co was 13.89. The lowest was 3.50. And the median was 6.38.


Tianjin Ringpu Bio-Technology Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co Cyclically Adjusted Revenue per Share Chart

Tianjin Ringpu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.37 2.74 3.10 3.40 3.64

Tianjin Ringpu Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 3.48 3.58 3.64 3.73

Competitive Comparison of Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio falls into.



Tianjin Ringpu Bio-Technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Ringpu Bio-Technology Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.157/115.2271*115.2271
=1.157

Current CPI (Mar. 2024) = 115.2271.

Tianjin Ringpu Bio-Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.387 98.200 0.454
201409 0.429 98.900 0.500
201412 0.358 99.000 0.417
201503 0.443 99.900 0.511
201506 0.425 99.500 0.492
201509 0.560 100.500 0.642
201512 0.610 100.600 0.699
201603 0.543 102.200 0.612
201606 0.614 101.400 0.698
201609 0.649 102.400 0.730
201612 0.653 102.600 0.733
201703 0.567 103.200 0.633
201706 0.604 103.100 0.675
201709 0.669 104.100 0.741
201712 0.749 104.500 0.826
201803 0.728 105.300 0.797
201806 0.714 104.900 0.784
201809 0.726 106.600 0.785
201812 0.774 106.500 0.837
201903 0.764 107.700 0.817
201906 0.873 107.700 0.934
201909 0.939 109.800 0.985
201912 1.097 111.200 1.137
202003 1.150 112.300 1.180
202006 1.190 110.400 1.242
202009 1.353 111.700 1.396
202012 1.358 111.500 1.403
202103 1.410 112.662 1.442
202106 1.211 111.769 1.248
202109 1.154 112.215 1.185
202112 1.215 113.108 1.238
202203 0.846 114.335 0.853
202206 1.119 114.558 1.126
202209 1.225 115.339 1.224
202212 1.310 115.116 1.311
202303 0.954 115.116 0.955
202306 1.189 114.558 1.196
202309 1.278 115.339 1.277
202312 1.431 114.781 1.437
202403 1.157 115.227 1.157

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Tianjin Ringpu Bio-Technology Co  (SZSE:300119) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.77/3.73
=4.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tianjin Ringpu Bio-Technology Co was 13.89. The lowest was 3.50. And the median was 6.38.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Tianjin Ringpu Bio-Technology Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Ringpu Bio-Technology Co (SZSE:300119) Business Description

Traded in Other Exchanges
N/A
Address
No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Headlines

No Headlines